FDA Commissioner Addresses Stakeholders at Kidney Health Initiative Meeting

Restricted access

Commissioner of the Food and Drug Administration Margaret A. Hamburg, MD, spoke at the Kidney Health Initiative’s first annual stakeholders meeting. In her opening remarks, Dr. Hamburg recognized ASN Past President Ronald J. Falk, MD, FASN, for his early leadership of the KHI initiative, KHI co-chairs Patrick Archdeacon, MD, of FDA’s Office of Medical Policy at the Center for Drug Evaluation and Research and Prabir Roy-Chaudhury, MD, PhD, FASN, professor at University of Cinncinati, as well as Melissa West, KHI project director. Following are Dr. Hamburg’s remarks to over 100 KHI members on September 11, 2013, in Rockville, MD